(NASDAQ:PDSB), PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that it has entered into a securities purchase agreement for the purchase and sale of 5,800,000 shares of common […]

PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering $5.3 million Upfront with up to an Additional $5.8 million of Aggregate Gross Proceeds upon the Cash Exercise in Full of Warrants GlobeNewswire November 11, 2025 PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a

AxisCare, a leading provider of home care management software, today announced the launch of AxisCare Intelligence, its new suite of AI-powered tools designed to help agencies work smarter, streamline operations, and elevate the quality of care they provide. https://mma.prnewswire.com/media/2643505/AxisCare_Logo.jpg Built directly into AxisCare's industry-leading home care management platform, AxisCare Intelligence delivers real-time insights, automation, and

ITG's Storyteq has been named a Leader in the Gartner® Magic Quadrant™ for Digital Asset Management, following its recognition as a Leader in CMP earlier this year. https://mma.prnewswire.com/media/2820214/ITG_powered_by_Storyteq_Logo.jpg “Our strategy is to develop Storyteq as the backbone of an AI-enabled content ecosystem.” – Andrew Swinand This is the second year in a row that the

XLCS Partners, Inc., a leading middle market investment bank, is pleased to announce it served as advisor to Mosaic Service Partners, a residential window and door replacement platform backed by Alpine Investors, on its investment in The Window Experts (formerly known as Houston Window Experts). https://mma.prnewswire.com/media/2820232/Mosaic_The_Window_Experts_XLCS.jpg Founded by Jeff Ludy and family, The Window Experts

WeNatal, the pioneering fertility and prenatal supplement brand created for both women and men, today announced the launch of Protein+, the first doctor-formulated 3-in-1 protein powder for both moms and dads-to-be. Available in two targeted formulations-a complete prenatal multivitamin, grass-fed whey protein, and collagen blend for her, and a men's preconception multivitamin, grass-fed whey protein,

VANCOUVER, British Columbia, Nov. 11, 2025 (GLOBE NEWSWIRE) — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company“) announces an extension of its non-brokered private placement financing (the “Offering“) previously announced on October 7, 2025, in order to provide sufficient time for additional investors to participate in the Offering. The Offering is expected

BioVaxys Announces Extension of Life Offering Closing Date GlobeNewswire November 11, 2025 VANCOUVER, British Columbia, Nov. 11, 2025 (GLOBE NEWSWIRE) — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company“) announces an extension of its non-brokered private placement financing (the “Offering“) previously announced on October 7, 2025, in order to provide sufficient time

(NYSE:MOH), NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the important December 2, 2025 lead plaintiff deadline. SO WHAT: If

MOH DEADLINE ALERT: ROSEN, A TOP RANKED GLOBAL LAW FIRM, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOH GlobeNewswire November 11, 2025 NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina